References
- Frederiksen S, Rasmussen A H. Effect of the Nl oxides of adenosine, 2′-deoxyadenosine and 3′-deoxyadenosine on tumor growth in vivo. Cancer Res 1967; 27: 385–391
- Svendsen K R, Overgaard-Hansen K, Frederiksen S, et al. Studies on the mechanism of cytotoxicity of 3′-deoxyadenosine N1-oxide in different strains of Ehrlich ascites tumor cells. Cancer Chemother Pharmacol 1987; 19: 118–122
- Svendsen K R, Overgaard-Hansen K, Frederiksen S. Synergistic effect of 3′-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo. Cancer Chemother Pharmacol 1988; 21: 35–39
- Svendsen K R, Overgaard-Hansen K, Frederiksen S, et al. Toxicity and metabolism of 3′-deoxy adenosine N1-oxide in mice and Ehrlich ascites tumor cells. Cancer Chemother Pharmacol 1992; 30: 86–94
- Steel G G. Therapeutic response of human xenografts in immune suppressed mice. Immune-Deficient Animals, B Sordat. Karger Press, Basel 1984; 395–404
- Moore G E, Gerner R E, Franklin H A. Culture of normal human leucocytes. JAMA 1967; 199: 519
- Rygaard K, Spang-Thomsen M. “Growth”—A computer program for determination of mean growth curves and calculation of response to therapy of solid tumor xenografts. Immune-Deficient Animals in Experimental Medicine, B-Q Wu, J Zhen. Karger Press, Basel 1989; 301–306
- Spang-Thomsen M, Nielsen A, Visfeldt J. Growth curves of three human malignant tumors transplanted to nude mice. Exp Cell Biol 1980; 48: 138–154
- Engelholm S AA, Vindeløv L L, Spang-Thomsen M, et al. Genetic instability of cell lines 'derived from a single human small cell carcinoma of the lung. Eur J Cancer Clin Oncol 1985; 21: 815–824
- Engelholm S AA, Spang-Thomsen M, Vindeløv L L, et al. Small cell lung cancer in patients, in vitro, and transplanted into nude mice. Acta Pathol Microbiol Scand Sec A 1986; 94: 325–336
- Steel G G, Courtenay V D, Peckham M J. The response to chemotherapy of a variety of human tumor xenografts. Br J Cancer 1983; 47: 1–13
- Bunn P A. The role of systemic chemotherapy in non-small lung cancer. Current Topics in Lung Cancer, P A Bunn. Springer-Verlag, Berlin 1991; 33–46
- Arnold A M. General review: Podophyllotoxi derivative VP-16–213. Cancer Chemother Pharmacol 1979; 3: 71–80
- Spang-Thomsen M, Roed H, Vindeløv L L. Effect of the two epipodophyllotoxins VP-16 and VM-26 on a small cell carcinoma of the lung xenograft grown in nude mice. Immune-Deficient Animals in Experimental Medicineq, B-Q Wu, J Zheng. Karger Press, Basel 1988; 268–273